Product Information
Name:CTS-1027
Brand:Biosynth
Description:CTS-1027 is a metalloprotease inhibitor that blocks the activity of matrix metalloprotease. CTS-1027 has been shown to inhibit HIV and also prevents tumor growth in mice. In vitro assays have shown that CTS-1027 inhibits the production of matrix metalloproteinase, which is associated with collagen degradation. The mechanism by which CTS-1027 inhibits matrix metalloproteinase is not known. This drug also has neuropathological effects, including the reduction of amyloid beta peptides in a mouse model of Alzheimer's disease. It also reduces the amount of amyloid beta peptides in a mouse model of Parkinson's disease and reduces the number of pathological cardiac cells in vivo models. Solid-phase synthesis was used to produce this compound at high purity levels.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:425.88 g/mol
Formula:C19H20ClNO6S
Purity:Min. 95%
Technical inquiry about: CTS-1027
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.